A. Spanevello (Tradate, Italy), I. Horváth (Budapest, Hungary)
Decreased expression of VEGF in the lungs of cigarettes smoke exposure mice
Y. Kasahara, K. Kobayashi, K. Kurosu, N. Tanabe, Y. Takiguchi, K. Tatsumi, T. Kuriyama (Chuo-ku, Japan)
|  |
Nitric oxide generation during human neutrophil respiratory burst is reduced by thiolic metabolite-1 of erdosteine (Met 1)
M. Culici, M. Dal Sasso, T. Bianchi, E. Fonti, C. Mancini, P. C. Braga (Milano, Italy)
| |
Leptin during COPD exacerbation
P. Kythreotis, P. Bakakos, D. Veldekis, E. Christodoulou, P. Iconomidis, A. Kokkini, A. Hadjioannou, A. Rasidakis (Athens, Greece)
| |
Serum uric acid levels among COPD patients
I. H. Lopez, M. E. B. Limpin, P. A. Punzal, T. S. de Guia (The Philippines)
| |
Insulin-like growth factor-I (IGF-I) in COPD exacerbation
P. Kythreotis, P. Bakakos, N. Lolis, E. Christodoulou, E. Ablianitis, A. Kokkini, A. Hadjioannou, A. Rasidakis (Athens, Greece)
| |
Consistency of inflammatory markers in blood in smokers and never smokers
K. Andelid, B. Bake, S. Rak, A. Ekberg-Jansson (Gothenburg, Sweden)
| |
Bronchial reversibility and airway inflammation in patients with COPD
A. Bugalho, I. Caires, H. Carvalho, N. Neuparth (Lisbon, Portugal)
| |
Increased levels of hyaluronan in induced sputum from COPD patients
J. H. Vernooy, M. A. Dentener, S. H. Hendriks, E. F. M. Wouters (Maastricht, The Netherlands)
| |
Expression of selected surface markers on macrophages in induced sputum from patients with COPD
J. J. Domagala-Kulawik, M. Maskey- Warzechowska, M. Dabrowska, I. Kraszewska, R. Chazan (Warsaw, Poland)
| |
Remodeling of respiratory muscles (RM) microvascular bed ultrastructure in COPD patients with different degree of respiratory failure (RF)
I. S. Platonova, B. G. Lisochkin (St Petersburg, Russia)
| |
Further evidence for a suppressive effect of theophylline on erythropoiesis
S. T. Tassiopoulos, A. E. Tsantes, A. D. Vlachou, S. A. Bonovas, N. C. Poulakis (Athens, Greece)
| |
Stress erythropoiesis may underlie macrocytosis in COPD
A. D. Vlachou, S. T. Tassiopoulos, S. I. Papadhimitriou, N. C. Poulakis (Athens, Greece)
| |
Characteristics of COPD-related deaths in Romania
O. Ailioaie, F. Mihaltan, P. Galbenu (Bucharest, Romania)
| |
Late ventricular potentials prevalence in patients with COPD
M. I. Carjea (Brad, Romania)
| |
Noninvasive detection of endothelial dysfunction in COPD
T. Coskun, C. Cuhadaroglu, H. Oflaz, T. Ece, E. Kocyigit (Istanbul, Turkey)
| |
Coagulation disorders in pulmonary hypertension. Correlations with haemodynamic data
K. Abou-hamdan, F. Chabot, P. Malvestio, J. M. Polu, T. Lecompte (France)
| |
Bronchial asthma mechanisms in the liquidators of the chornobyl catastrophe
V. A. Sushko, A. N. Kovalenko (Kyiv, Ukraine)
| |
Bronchial dilatation in asthma: relation to clinical and sputum indices
M. Takemura, A. Niimi, M. Minakuchi, H. Matsumoto, T. Ueda, K. Chin, M. Mishima (Kyoto, Nara, Japan)
| |
Effect of cilomilast on trapped gas volume and indices of hyperinflation in patients with COPD
D. Horstman, N. Zamel, P. McClean, J. Zhu, K. Singh, C. Reisner (Research Triangle Park, United States Of America; Toronto, Canada)
| |
Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD
H. J. Pennings, M. A. Dentener, E. Dompeling, Q. Jobsis, E. F. M. Wouters (Horn, Maastricht, The Netherlands)
| |